Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-20-019714
Date:2020-07-17
Issuer: CORCEPT THERAPEUTICS INC (CORT)
Original Submission Date:

Reporting Person:

SWISHER DANIEL N JR
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE MENLO PARK, CA 94025

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-07-17 M 5,000 a $6.55 5,000 direct
COMMON STOCK 2020-07-17 S 5,000 d $16.48 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.55 2020-07-17 deemed execution date M 5,000 (d) 2025-06-18 common stock 5,000 $6.55 60,000 direct
Footnotes
IDfootnote
f1 the transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
f2 represents the weighted average sale price for the entire number of shares sold. the actual sale prices range from $16.37 to $16.62 per share. detailed information on the exact number of shares sold at each sale price can be obtained from issuer upon request.
f3 fully exercisable.
WhaleWisdom Logo

Elevate your investments